Jackson, Carlayne E
93  results:
Search for persons X
?
3

COURAGE-ALS: a randomized, double-blind phase 3 study desig..:

Shefner, Jeremy M. ; Al-Chalabi, Ammar ; Andrews, Jinsy A....
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.  24 (2023)  5-6 - p. 523-534 , 2023
 
?
4

Oral Edaravone – Introducing a Flexible Treatment Option fo..:

Pattee, Gary L. ; Genge, Angela ; Couratier, Philippe...
Expert Review of Neurotherapeutics.  23 (2023)  10 - p. 859-866 , 2023
 
?
 
?
8

MiToS and King's staging as clinical outcome measures in AL..:

Gebrehiwet, Paulos ; Meng, Lisa ; Rudnicki, Stacy A....
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.  24 (2022)  3-4 - p. 304-310 , 2022
 
?
9

Pulmonary function decline in amyotrophic lateral sclerosis:

Heiman-Patterson, Terry D. ; Khazaal, Ossama ; Yu, Daohai...
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.  22 (2021)  sup1 - p. 54-61 , 2021
 
?
10

Use of a new ALS specific respiratory questionnaire: the AR..:

Heiman-Patterson, Terry D. ; Sherman, Michael S. ; Yu, Daohai...
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.  22 (2021)  sup1 - p. 48-53 , 2021
 
?
14

Real-world evidence of riluzole effectiveness in treating a..:

Andrews, Jinsy A. ; Jackson, Carlayne E. ; Heiman-Patterson, Terry D....
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.  21 (2020)  7-8 - p. 509-518 , 2020
 
1-15